Roche lifts 2019 outlook as first-quarter sales beat forecasts
April 17, 2019 at 01:25 AM EDT
Swiss drugmaker Roche raised its 2019 outlook after first-quarter sales beat analyst forecasts on the strength of newer medicines including multiple sclerosis treatment Ocrevus and cancer immunotherapy Tecentriq.
